Results 1 to 10 of about 6,880 (240)
Aciclovir‐resistenter Zoster disseminatus bei chronischer lymphatischer B‐Zell‐Leukämie [PDF]
JDDG: Journal der Deutschen Dermatologischen Gesellschaft, Volume 24, Issue 1, Page 87-90, January 2026.
Turan T +3 more
europepmc +2 more sources
Some of the next articles are maybe not open access.
Journal of Antimicrobial Chemotherapy
BACKGROUND Valaciclovir is frequently prescribed for cytomegalovirus infection prophylaxis. Its major metabolite 9-carboxymethoxymethylguanine (9-CMMG), when accumulated in renally impaired patients, is neurotoxic.
B. Kably +8 more
semanticscholar +1 more source
BACKGROUND Valaciclovir is frequently prescribed for cytomegalovirus infection prophylaxis. Its major metabolite 9-carboxymethoxymethylguanine (9-CMMG), when accumulated in renally impaired patients, is neurotoxic.
B. Kably +8 more
semanticscholar +1 more source
Expert Review of Clinical Pharmacology, 2023
Objective This study aimed to explore a comprehensive empirical investigation and assess SCARs related to valaciclovir or acyclovir based on FAERS database from FDA, thus providing a theoretical foundation for the rational application of drugs in clinic.
KaiLi Mao +5 more
semanticscholar +1 more source
Objective This study aimed to explore a comprehensive empirical investigation and assess SCARs related to valaciclovir or acyclovir based on FAERS database from FDA, thus providing a theoretical foundation for the rational application of drugs in clinic.
KaiLi Mao +5 more
semanticscholar +1 more source
Cytomegalovirus congenital infection: long-term outcomes in a valaciclovir treated population
Journal of Perinatal MedicineObjectives This case series aims to evaluate the long-term outcomes of congenital cytomegalovirus (CMV) infection in a population treated with valaciclovir during pregnancy.
Maria Vicente +4 more
semanticscholar +1 more source

